Slide 1 Slide 2 Achieving A1C and Glycemic Targets with Insulin What to Do When Oral Agents Fail New Paradigms, Guidelines, and Evolving Strategies JUAN P. FRIAS, M.D., FACE…
Slide 1The Case for Going Coo-coo for Cacao -data, from the dark side- David L. Katz, MD, MPH, FACPM, FACP Director, Prevention Research Center Yale University School of…
Folie 1 Nitrattherapie und Nitratresistenz – Implikationen für Diabetes mellitus und KHK Nitrattherapie und Nitratresistenz – Implikationen für Diabetes mellitus und…
Dia 1 09-Aug-2008-JAN-2007-BE-1263-SS Adapted from Buse JB et al. In Williams Textbook of Endocrinology. 10th ed. Philadelphia, Saunders, 2003:1427–1483; Buchanan TA Clin…
1. San Francisco – June 16th, 2014 IR Thematic Call on Diabetes 2. 2 Sanofi Forward Looking Statements This presentation contains forward-looking statements as defined…
SULFONILUREAS VS INCRETINAS VENTAJAS Y OPORTUNIDADES Dr. Luis More Saldaña Hospital Santa Rosa /Clínica San Felipe Endocrinólogo Terapia Escalonada en el Tratamiento de…
Saat diagnosis: Gaya hidup + Metformin Gaya hidup + Metformin + Insulin basal Gaya hidup + Metformin + Sulfonilurea Gaya hidup + Metformin + Insulin intensif Gaya hidup +…
Slide 1 Using Insulin in the Primary Care Setting: Interactive Cases Irl B. Hirsch, MD University of Washington School of Medicine Slide 2 Dualities (Nov, 2011) Research…